Advertisement
News
Advertisement

Celldex launches Phase 3 trial of brain cancer drug

Thu, 12/01/2011 - 9:35am
Mass High Tech: The Journal of New England Technology

Needham’s Celldex Therapeutics Inc. is starting a Phase 3 trial for its rindopepimut treatment of glioblastoma tumors, a malignant and aggressive form of brain cancer.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading